Amplify Weight Loss Drug & Treatment ETF (THNR)

THNR Holdings Information

THNR is an equity ETF with a total of 24 individual holdings. The top holdings are Novo Nordisk stock at 11.92%, Eli Lilly and Company at 11.71%, Regeneron Pharmaceuticals at 6.72%, Amgen at 6.13%, and Chugai Pharmaceutical at 6.10%.

• Total Holdings: 24
• Top 10 Percentage: 68.76%
• Asset Class: Equity
• ETF Category: Health
• Assets: 4.19M
• PE Ratio: 18.91

Top 25 Holdings

As of Apr 2, 2026

Filter results

No.	Symbol	Name	% Weight	Shares
1	NVO	Novo Nordisk A/S	11.92%	13,608
2	LLY	Eli Lilly and Company	11.71%	529
3	REGN	Regeneron Pharmaceuticals, Inc.	6.72%	369
4	AMGN	Amgen Inc.	6.13%	749
5	TYO: 4519	Chugai Pharmaceutical Co., Ltd.	6.10%	4,600
6	HKG: 1801	Innovent Biologics, Inc.	5.58%	20,000
7	HKG: 1093	CSPC Pharmaceutical Group Limited	5.33%	180,000
8	LON: AZN	AstraZeneca PLC	5.15%	1,063
9	MRK	Merck & Co., Inc.	5.09%	1,763
10	PFE	Pfizer Inc.	5.05%	7,606
11	TYO: 4507	Shionogi & Co., Ltd.	4.98%	9,300
12	SWX: ROP	Roche Holding AG	4.85%	510
13	ARWR	Arrowhead Pharmaceuticals, Inc.	4.80%	3,287
14	ABBV	AbbVie Inc.	4.48%	907
15	SRRK	Scholar Rock Holding Corporation	2.34%	2,005
16	VKTX	Viking Therapeutics, Inc.	2.28%	2,818
17	GPCR	Structure Therapeutics Inc.	2.15%	1,738
18	CPH: ZEAL	Zealand Pharma A/S	1.74%	1,584
19	AGPXX	Short-Term Investment Trust - Invesco Government & Agency Portfolio	1.35%	56,639
20	JNGHF	Jiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H	1.26%	6,200
21	KRX: 128940	Hanmi Pharm. Co., Ltd.	1.25%	158
22	n/a	US DOLLARS	0.37%	15,654
23	n/a	JAPANESE YEN	0.06%	423,256
24	n/a	OTHER ASSETS AND LIABILITIES	-0.68%	156,845,551